Trading · Founded 1983 · www.continentalseeds.co.in · NSE · ISIN INE340Z01019
No Notes Added Yet
Business
Continental Seeds and Chemicals Ltd. (CONTI) operates primarily in the trading sector within India. The company's core business involves the procurement and distribution of agricultural inputs, specifically seeds and various chemicals. Its business model revolves around sourcing these products from manufacturers or larger suppliers and then distributing them to a network of retailers, distributors, or directly to end-users (farmers) across different regions. The company makes money through the margin it earns on the sale of these goods, which is the difference between its purchase price and its selling price, factoring in logistics and operational costs.
Revenue Mix
Based on the company name, its primary segments are likely:
Seeds Trading: Involving the sourcing and distribution of various types of agricultural seeds (e.g., field crops, vegetable seeds).
Chemicals Trading: Encompassing a range of chemicals, potentially including agrochemicals (pesticides, fertilizers, herbicides), or other industrial chemicals, depending on the company's specific focus.
Specific revenue contribution percentages for each segment are not publicly available without financial reports.
Industry
The company operates in the trading industry, specifically within the agricultural input supply chain in India. This industry is generally fragmented, characterized by numerous small to medium-sized traders and distributors alongside larger, more integrated players. The competitive landscape is often intense, driven by price sensitivity, product availability, and established distribution networks. Continental Seeds and Chemicals Ltd. likely positions itself by leveraging its supplier relationships, regional distribution strength, and product portfolio to cater to specific market demands within India's vast agricultural sector.
MOAT
As a pure trading company, Continental Seeds and Chemicals Ltd. faces challenges in establishing a strong, durable competitive advantage. Potential moats are generally weaker for trading businesses compared to manufacturing or technology firms. Any competitive advantage would likely stem from:
Efficient Logistics & Supply Chain: Ability to procure and distribute products efficiently and cost-effectively.
Strong Supplier & Customer Relationships: Established long-term relationships that provide preferential terms or reliable off-take agreements.
Distribution Network: A wide and effective network reaching remote agricultural areas.
Scale: Achieving scale that allows for better pricing power with suppliers or lower per-unit distribution costs.
However, these advantages are often difficult to sustain against competitors and can be subject to market dynamics.
Growth Drivers
Key factors that could drive growth for Continental Seeds and Chemicals Ltd. over the next 3-5 years include:
Growth in Indian Agriculture: Overall expansion and modernization of the Indian agricultural sector, leading to increased demand for quality seeds and agrochemicals.
Product Portfolio Expansion: Introducing new types of seeds or chemicals to cater to evolving farmer needs and crop patterns.
Geographical Expansion: Extending its distribution network into new regions or states within India.
Government Initiatives: Favorable government policies and support for agriculture, including subsidies or infrastructure development.
Technological Adoption: Increased adoption of advanced farming practices and specialized inputs by farmers.
Risks
Commodity Price Volatility: Fluctuations in the prices of seeds and chemicals can impact procurement costs and selling prices, affecting margins.
Monsoon Dependence: The performance of the Indian agricultural sector is heavily reliant on monsoon patterns, which can directly affect demand for agricultural inputs.
Intense Competition: A fragmented and competitive market can lead to pressure on trading margins.
Supply Chain Disruptions: Risks associated with sourcing, logistics, and inventory management, including supplier reliability and transportation bottlenecks.
Regulatory Changes: Evolving regulations concerning seed quality, chemical usage, import/export policies, and trade can impact operations.
Working Capital Management: Trading businesses typically require significant working capital, and efficient management of receivables and inventory is crucial.
Management & Ownership
As a listed Indian company, Continental Seeds and Chemicals Ltd. is typically driven by a promoter group (founding family or individuals) who hold a significant stake and often play a key role in management. Specific details regarding the quality of management, their track record, or the exact ownership structure (e.g., promoter vs. public vs. institutional holdings) are not available without further research into their corporate filings. Generally, promoter-led companies in India benefit from long-term vision but can also have governance concerns if not properly managed.
Outlook
Continental Seeds and Chemicals Ltd. operates in an essential segment of the Indian economy – agriculture – which offers inherent long-term growth potential due to population growth and food security needs. The company's ability to capitalize on this growth will depend on its operational efficiency, strength of its distribution network, and capacity to manage market volatility. The outlook is balanced: while demand for agricultural inputs is generally stable, the trading business is characterized by thin margins, intense competition, and exposure to external factors like weather patterns and commodity price fluctuations. Success will hinge on disciplined inventory management, strong supplier and customer relationships, and strategic expansion in a dynamic market.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
| #(Fig in Cr.) |
|---|
| Net Sales |
| Other Income |
| Total Income |
| Total Expenditure |
| Operating Profit |
| Interest |
| Depreciation |
| Exceptional Income / Expenses |
| Profit Before Tax |
| Provision for Tax |
| Profit After Tax |
| Adjustments |
| Profit After Adjustments |
| Adjusted Earnings Per Share |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 58 | 58 | 58 | 82 | 82 | 88 | 95 | 98 | 75 | 98 | 91 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
| Total Income | 58 | 58 | 58 | 82 | 82 | 88 | 96 | 98 | 76 | 99 | 92 | |
| Total Expenditure | 57 | 58 | 57 | 80 | 80 | 86 | 94 | 96 | 71 | 98 | 88 | |
| Operating Profit | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 1 | 4 | |
| Interest | 0 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 1 | 1 | 0 | |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 4 | 3 | 2 | |
| Exceptional Income / Expenses | 0 | 0 | -0 | -0 | -0 | 0 | -0 | -0 | -0 | 3 | 2 | |
| Profit Before Tax | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 2 | |
| Provision for Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Tax | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | |
| Adjustments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Profit After Adjustments | 0 | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 2 | |
| Adjusted Earnings Per Share | 0.4 | 0.2 | 0.6 | 0.7 | 0.5 | 0.6 | 0.4 | 0.2 | 0 | 0.7 | 1.4 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -7% | -2% | 1% | 5% |
| Operating Profit CAGR | 300% | 26% | 15% | 15% |
| PAT CAGR | 100% | 0% | 15% | 0% |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Share Price CAGR | -61% | -33% | 7% | NA% |
| ROE Average | 10% | 5% | 4% | 5% |
| ROCE Average | 10% | 7% | 6% | 9% |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Shareholder's Funds | 5 | 5 | 6 | 11 | 11 | 12 | 12 | 12 | 12 | 13 | 28 |
| Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrowings | 0 | 1 | 1 | 1 | 0 | 0 | 2 | 2 | 3 | 2 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 4 | 3 | 1 |
| Total Current Liabilities | 4 | 6 | 6 | 25 | 17 | 9 | 18 | 17 | 12 | 9 | 7 |
| Total Liabilities | 9 | 12 | 13 | 36 | 29 | 22 | 33 | 32 | 31 | 26 | 36 |
| Fixed Assets | 0 | 0 | 2 | 1 | 2 | 3 | 5 | 21 | 18 | 16 | 15 |
| Other Non-Current Assets | 1 | 1 | 0 | 1 | 7 | 7 | 14 | 2 | 2 | 3 | 2 |
| Total Current Assets | 8 | 11 | 11 | 34 | 20 | 12 | 14 | 9 | 10 | 8 | 19 |
| Total Assets | 9 | 12 | 13 | 36 | 29 | 22 | 33 | 32 | 31 | 26 | 36 |
| #(Fig in Cr.) | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Opening Cash & Cash Equivalents | 2 | 1 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 0 | 0 |
| Cash Flow from Operating Activities | -3 | -2 | 2 | 1 | -2 | 5 | 7 | 8 | 6 | 3 | -10 |
| Cash Flow from Investing Activities | 0 | 0 | -1 | 0 | -2 | -4 | -8 | -7 | -1 | -1 | -2 |
| Cash Flow from Financing Activities | 2 | 1 | -0 | 3 | -1 | -1 | 1 | -0 | -0 | -2 | 12 |
| Net Cash Inflow / Outflow | -1 | -1 | -0 | 4 | -4 | 0 | -0 | 0 | 5 | 0 | 0 |
| Closing Cash & Cash Equivalent | 1 | 0 | 0 | 4 | 0 | 0 | 0 | 1 | 6 | 0 | 0 |
| # | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Per Share (Rs) | 0.36 | 0.22 | 0.64 | 0.72 | 0.46 | 0.65 | 0.37 | 0.19 | 0.02 | 0.67 | 1.44 |
| CEPS(Rs) | 0.69 | 0.36 | 0.92 | 0.98 | 0.73 | 1.09 | 0.99 | 1.44 | 3.54 | 3.64 | 3.4 |
| DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Book NAV/Share(Rs) | 6.87 | 7.09 | 7.75 | 10.59 | 11.03 | 11.68 | 12.03 | 12.23 | 12.3 | 12.69 | 17.61 |
| Core EBITDA Margin(%) | 1.54 | 1.33 | 2.54 | 2.25 | 2.09 | 1.63 | 1.55 | 1.82 | 5.19 | -0.06 | 3.07 |
| EBIT Margin(%) | 1.29 | 1.27 | 2.29 | 2.05 | 1.89 | 1.49 | 1.18 | 0.78 | 0.74 | 1.37 | 2.86 |
| Pre Tax Margin(%) | 0.67 | 0.39 | 1.21 | 1.3 | 1.04 | 0.98 | 0.51 | 0.38 | 0.03 | 0.82 | 2.42 |
| PAT Margin (%) | 0.46 | 0.28 | 0.81 | 0.88 | 0.57 | 0.74 | 0.39 | 0.19 | 0.02 | 0.68 | 2.01 |
| Cash Profit Margin (%) | 0.87 | 0.45 | 1.15 | 1.19 | 0.89 | 1.24 | 1.04 | 1.47 | 4.69 | 3.72 | 4.76 |
| ROA(%) | 3.65 | 1.52 | 3.78 | 2.94 | 1.43 | 2.54 | 1.35 | 0.58 | 0.05 | 2.35 | 5.84 |
| ROE(%) | 5.45 | 3.17 | 8.64 | 8.87 | 4.3 | 5.71 | 3.16 | 1.54 | 0.13 | 5.33 | 10.41 |
| ROCE(%) | 12.07 | 8.84 | 13.67 | 13.61 | 10.69 | 8.79 | 6.83 | 4.29 | 3.05 | 7.3 | 10.29 |
| Receivable days | 7.09 | 25.95 | 40.25 | 69.18 | 84.12 | 33.34 | 23.02 | 21.22 | 15.05 | 13.25 | 19.09 |
| Inventory Days | 16.59 | 24.95 | 19.81 | 15.24 | 15.8 | 17.65 | 16.08 | 13.4 | 16.08 | 11.39 | 26.19 |
| Payable days | 2.71 | 9.5 | 6.99 | 47.87 | 77.18 | 34.19 | 16.97 | 33.94 | 49.12 | 16.89 | 7.93 |
| PER(x) | 0 | 0 | 0 | 0 | 16.98 | 34.95 | 16.01 | 55.05 | 772.73 | 34.46 | 20.18 |
| Price/Book(x) | 0 | 0 | 0 | 0 | 0.72 | 1.94 | 0.5 | 0.84 | 1.04 | 1.81 | 1.65 |
| Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EV/Net Sales(x) | 0.05 | 0.09 | 0.1 | 0.07 | 0.14 | 0.29 | 0.12 | 0.15 | 0.25 | 0.29 | 0.45 |
| EV/Core EBITDA(x) | 3.2 | 6.17 | 3.8 | 2.83 | 6.23 | 15.5 | 6.41 | 7.39 | 4.58 | 24.95 | 11.41 |
| Net Sales Growth(%) | 5.83 | 0.98 | -0.33 | 40.28 | 0.59 | 7.08 | 8.51 | 2.62 | -22.97 | 29.53 | -7.09 |
| EBIT Growth(%) | 155.71 | -0.46 | 79.36 | 25.97 | -7.38 | -15.73 | -14.08 | -31.81 | -27.62 | 140.81 | 94 |
| PAT Growth(%) | 23.03 | -39.25 | 189.86 | 53.98 | -35.53 | 39.41 | -42.16 | -50.09 | -91.18 | 3936.97 | 174.03 |
| EPS Growth(%) | 23.03 | -39.25 | 189.86 | 12.42 | -35.54 | 39.41 | -42.16 | -50.08 | -91.18 | 3935.76 | 115.8 |
| Debt/Equity(x) | 0.52 | 0.78 | 0.82 | 0.35 | 0.33 | 0.29 | 0.49 | 0.46 | 0.5 | 0.43 | 0.17 |
| Current Ratio(x) | 2.05 | 1.93 | 2 | 1.37 | 1.15 | 1.3 | 0.81 | 0.51 | 0.87 | 0.89 | 2.82 |
| Quick Ratio(x) | 0.79 | 1.41 | 1.41 | 1.23 | 0.94 | 0.75 | 0.62 | 0.29 | 0.62 | 0.54 | 1.43 |
| Interest Cover(x) | 2.08 | 1.44 | 2.13 | 2.72 | 2.23 | 2.92 | 1.76 | 1.96 | 1.04 | 2.48 | 6.55 |
| Total Debt/Mcap(x) | 0 | 0 | 0 | 0 | 0.47 | 0.15 | 0.98 | 0.55 | 0.48 | 0.24 | 0.11 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.27 | 72.27 | 65.71 | 65.71 | 56.91 | 58.55 | 58.55 | 60.06 | 60.75 | 60.75 |
| FII | 0 | 0 | 0 | 0 | 13.38 | 12.88 | 12.88 | 12.41 | 12.19 | 12.19 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 27.73 | 27.73 | 34.29 | 34.29 | 29.7 | 28.58 | 28.58 | 27.54 | 27.06 | 27.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 | 0.77 | 0.77 | 0.82 | 0.85 | 0.85 |
| FII | 0 | 0 | 0 | 0 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.28 | 0.28 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1.1 | 1.1 | 1.27 | 1.32 | 1.32 | 1.37 | 1.39 | 1.39 |
| # | 1 Year | 3 Year | 5 Year | 10 Year |
|---|---|---|---|---|
| Sales CAGR | -7% | -2% | +1% | +5% |
| Operating Profit CAGR | +300% | +26% | +15% | +15% |
| PAT CAGR | +100% | — | +15% | — |
| Share Price CAGR | -61% | -33% | +7% | — |
| ROE Average | +10% | +5% | +4% | +5% |
| ROCE Average | +10% | +7% | +6% | +9% |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 72.27 | 72.27 | 65.71 | 65.71 | 56.91 | 58.55 | 58.55 | 60.06 | 60.75 | 60.75 |
| FII | 0 | 0 | 0 | 0 | 13.38 | 12.88 | 12.88 | 12.41 | 12.19 | 12.19 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 27.73 | 27.73 | 34.29 | 34.29 | 29.7 | 28.58 | 28.58 | 27.54 | 27.06 | 27.06 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| # | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Promoter | 0.72 | 0.72 | 0.72 | 0.72 | 0.72 | 0.77 | 0.77 | 0.82 | 0.85 | 0.85 |
| FII | 0 | 0 | 0 | 0 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 | 0.17 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 0.28 | 0.28 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 | 0.38 |
| Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1.1 | 1.1 | 1.27 | 1.32 | 1.32 | 1.37 | 1.39 | 1.39 |
* The pros and cons are machine generated.
Our experts help you choose the right stocks based on performance, risk, and growth potential.
Looking to buy unlisted shares or need guidance on the investment process? Our expert Private Equity Advisors are here to assist you with accurate information, real-time pricing, and seamless execution.
Want to sell unlisted shares, liquidate your ESOPs, or understand the step-by-step process of liquidation? Connect with our Buying Team for smooth coordination, quick evaluations, and end-to-end support.
Planning to build or grow your portfolio? For Mutual Fund investments, PMS solutions, tailored portfolio creation, and overall wealth management, our dedicated Wealth Team is ready to guide you.
Your relationship manager will connect with you shortly.